Pristipino Christian, Pelliccia Francesco, Granatelli Antonino, Pasceri Vincenzo, Roncella Adriana, Speciale Giulio, Hassan Timoor, Richichi Giuseppe
"Ricerche Orientate sulla Malattia Aterosclerotica" Core Laboratory and Coronary Intervention Unit, San Filippo Neri Hospital, Rome, Italy.
Am J Cardiol. 2007 May 1;99(9):1216-21. doi: 10.1016/j.amjcard.2006.12.038. Epub 2007 Mar 15.
Women constitute a high-risk population for bleeding, which is a major prognostic predictor after percutaneous coronary catheterization procedures. We prospectively followed 3,261 consecutive percutaneous coronary procedures performed by radial artery catheterization (RAC) or femoral artery catheterization (FAC). The primary study objective was to determine the relative incidences of in-hospital major and minor puncture-related hemorrhages. Secondary objectives were to (1) identify predictors of major bleeds and (2) estimate how often a second, alternative access site is required for catheterization. In women, no major bleeding occurred after 299 RAC procedures performed, whereas 25 major bleeding episodes occurred after 601 FAC procedures (p = 0.0008). Women who underwent RAC also had a significantly lower incidence of minor hemorrhages than women who underwent FAC (19 of 299, 6.4%, vs 237 of 601, 39.4%, respectively, p = 0.00001). On multivariate analysis, independent predictors of major bleeding were FAC (odds ratio [OR] 27.4, 95% confidence interval [CI] 3.8 to 199.9), use of glycoprotein IIb/IIIa inhibitors (OR 5.6, 95% CI 2.7 to 11.9), female gender (OR 4.5, 95% CI 2.2 to 9.0), age >70 years (OR 2.4, 95% CI 1.2 to 4.8), and an acute coronary syndrome setting (OR 2.4, 95% CI 1.1 to 5.0). Women who underwent RAC were more likely to require a second access site than men (14% vs 1.7%), but operators less selective in RAC use successfully completed the procedure by radial approach in >90% of patients. In conclusion, extensive RAC was more effective at preventing access-related bleeding complications in women than FAC.
女性是出血的高危人群,出血是经皮冠状动脉导管插入术后的一个主要预后预测指标。我们对连续进行的3261例经桡动脉导管插入术(RAC)或股动脉导管插入术(FAC)的经皮冠状动脉手术进行了前瞻性随访。主要研究目标是确定院内主要和次要穿刺相关出血的相对发生率。次要目标是:(1)确定大出血的预测因素;(2)估计导管插入术需要第二个替代穿刺部位的频率。在女性中,299例RAC手术后未发生大出血,而601例FAC手术后发生了25例大出血事件(p = 0.0008)。接受RAC的女性小出血发生率也显著低于接受FAC的女性(分别为299例中的19例,6.4%, vs 601例中的237例,39.4%,p = 0.00001)。多变量分析显示,大出血的独立预测因素为FAC(比值比[OR] 27.4,95%置信区间[CI] 3.8至199.9)、糖蛋白IIb/IIIa抑制剂的使用(OR 5.6,95% CI 2.7至11.9)、女性性别(OR 4.5,95% CI 2.2至9.0)、年龄>70岁(OR 2.4,95% CI 1.2至4.8)以及急性冠状动脉综合征情况(OR 2.4,95% CI 1.1至5.0)。接受RAC的女性比男性更有可能需要第二个穿刺部位(14% vs 1.7%),但在RAC使用上选择性较低的操作人员在超过90%的患者中通过桡动脉途径成功完成了手术。总之,广泛应用RAC在预防女性穿刺相关出血并发症方面比FAC更有效。